MAI Capital Management’s Zymeworks ZYME Stock Holding History

MAI Capital Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$176	Buy	7 +2	+40%	+$47	﹤0.01%	4650
2025 Q4	$132	Buy	+5	New	+$109	﹤0.01%	4120

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

MAI Capital Management's ZYME Position: Q1 2026 in Review

MAI Capital Management increased its Zymeworks (ZYME) stake by 40% in Q1 2026, buying an estimated $47 and bringing the position to 7 shares worth $176. The position accounts for ﹤0.01% of the portfolio, ranked #4650.

MAI Capital Management first reported a position in ZYME in Q4 2025 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

MAI Capital Management held 7 shares of Zymeworks worth $176 as of Q1 2026.
MAI Capital Management bought 2 Zymeworks shares in Q1 2026, an estimated $47.
Zymeworks made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4650 holding.
MAI Capital Management first reported a position in Zymeworks in Q4 2025 and has held it in 2 quarters since.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.